TotalMarketCap

Ascentage Pharma Group International

AAPGNasdaq ChinaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.412 B

$15.13 +0.40%

Close of 6 Nov 2026

As of 6 Nov 2026, Ascentage Pharma Group International (AAPG) has a market capitalization of $1.41B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

373,322,192

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #118Tyra BiosciencesTYRA$1.43B
  2. #119Ocular TherapeutixOCUL$1.41B
  3. #120Ascentage Pharma Group InternationalAAPG$1.41B
  4. #121Rapport TherapeuticsRAPP$1.41B
  5. #122ADARx PharmaceuticalsADRX$1.41B

What if Ascentage Pharma Group International were worth as much as…

Open the what-if tool →

Gold $28.2T

$302,546.96

Per share 19,996× higher

Bitcoin $1.53T

$16,370.29

Per share 1,082× higher

Apple $5.02T

$53,742.13

Per share 3,552× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Ascentage Pharma Group International are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.